Economy News / Baghdad announced that the General Company for the manufacture of medicines and medical supplies in Samarra, on Sunday, achieving an increase in sales by up to 15% during the first half of the current 2016, sales for the same period last year, while attributed the higher sales to follow the "new policy and deliberate "in marketing. The Media Center at the Ministry of Industry and Minerals Director Abdul Wahid al-Shammari in a statement received by the "Economy News", a copy of it, that "public company for the pharmaceutical industry in Samarra, one of the Ministry of Industry and Minerals has achieved sales of over 21 billion dinars in the first six months of this year "noting that" this represents an increase in the company's sales during the first six months of this year, compared with what has been achieved during the same period last year, and by the development amounted to 15%. " He said al-Shammari, said: "This rise in sales recorded was due to follow new and deliberate policy of marketing by exploiting the marketing outlets deployed in Baghdad and all the provinces and the implementation of an intensive promotional campaigns, as well as direct and continuous coordination with government institutions, particularly the Ministry of Health," noting that " the company decided earlier in the granting of an exclusive three agencies to market their products duration of three years, renewable provided that the student agency to submit the offer for the purpose of study by the company. " He said al-Shammari, "The company also launched new products and mobilization Balbakit bulletin, after the completion of the necessary supplies to work processing," she returned to "the evolution of the company is the result of continuous work and efforts to improve the industrial reality of Iraq." The General Company for the manufacture of medicines and medical supplies in Samarra, announced in February of 2016, the current, achieve a higher percentage of sales in years, as revealed its intention to implement a propaganda operation to their products. The General Company for the manufacture of medicines and medical supplies in Samarra, which was founded in 1965 and started trial production in 1973, one of the largest drug producers in Iraq, followed by the General Company for the manufacture of medicines and medical supplies in Nineveh, which was founded in 2002, the two aircraft to the Ministry of Industry and Minerals, as well as dozens of companies and pharmaceutical laboratories for varying sizes and capabilities. The Iraqi industry, including pharmaceutical, suffer so much because of foreign competition and the reluctance of local authorities to buy their products, the Council of Ministers had to guide the state departments need to deal with the national industrial entities. AJ
SOURCE
SOURCE